Obesity and cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

39 citing papers in PubMed.

1. Addition of Phentermine-Topiramate to a Digitally Enhanced Lifestyle Intervention: A Double-Blind Randomized Clinical Trial.Obesity (Silver Spring, Md.) · 2026
   Trial
2. Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2015
   Trial
3. A Novel CYP2E1 Inhibitor, 4-Methyl-5-Acetylthiazole (Q11), Alleviates Obesity Via Modulating Adipose Inflammation and Mitochondrial Dysfunction.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
   Article
4. Understanding obesity-cancer crosstalk to inform the immunomodulatory roles of anti-obesity nanotherapeutics.Materials today. Bio · 2026
   Review
5. Cryo-EM structure of the full-length LGR4-RSPOs complex and a targeting nanobody for anti-obesity therapy.Nature communications · 2025
   Article
6. Dual inhibition of carbonic anhydrases VA and VII by silychristin and isosilybin A from Silybum marianum: A potential antiobesity strategy.Archiv der Pharmazie · 2025
   Article
7. Constitutively active receptor ADGRA3 signaling induces adipose thermogenesis.eLife · 2024
   Article
8. Inhibitory Activity ofJournal of microbiology and biotechnology · 2024
   Article
9. Implications of NLRP3 Suppression Using Glibenclamide and miR-223 against Colorectal Cancer.Pharmaceuticals (Basel, Switzerland) · 2024
   Article
10. The association between weight change patterns and obesity-related complex multimorbidity: evidence from NHANES.Frontiers in endocrinology · 2024
    Article
11. The role of macrophage and adipocyte mitochondrial dysfunction in the pathogenesis of obesity.Frontiers in immunology · 2024
    Review
12. Metabolic and Bariatric Endoscopy: A Mini-Review.Life (Basel, Switzerland) · 2023
    Review
13. A prospective cohort study of infertility and cancer incidence.Fertility and sterility · 2023
    Article
14. Anti-obesity drug discovery: advances and challenges.Nature reviews. Drug discovery · 2022
    Review
15. Visceral Adiposity Index in Breast Cancer Survivors: A Case-Control Study.International journal of endocrinology · 2020
    Article
16. From NASH to HCC: current concepts and future challenges.Nature reviews. Gastroenterology & hepatology · 2019
    Review
17. Performance of prostate cancer recurrence nomograms by obesity status: a retrospective analysis of a radical prostatectomy cohort.BMC cancer · 2018
    Article
18. Inflammation and Colorectal Cancer.Current colorectal cancer reports · 2017
    Article
19. Obesity-Related Digestive Diseases and Their Pathophysiology.Gut and liver · 2017
    Review
20. Exposure to a diet high in fat attenuates dendritic spine density in the medial prefrontal cortex.Brain structure & function · 2017
    Article

Corrections and comments

• Comment on
  Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study.2007

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as